T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2

Phospholipase A2 (PLA) is a biochemically fully defined glycoprotein, representing the main allergen of bee venom. We have established CD4+ T cell clones specific to PLA from subjects allergic and nonallergic to bee sting. By screening the epitope specificity of these clones with 62 synthetic overla...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 150; no. 8; pp. 3582 - 3591
Main Authors Carballido, JM, Carballido-Perrig, N, Kagi, MK, Meloen, RH, Wuthrich, B, Heusser, CH, Blaser, K
Format Journal Article
LanguageEnglish
Published Bethesda, MD Am Assoc Immnol 15.04.1993
American Association of Immunologists
Subjects
Online AccessGet full text
ISSN0022-1767
1550-6606
1550-6606
DOI10.4049/jimmunol.150.8.3582

Cover

More Information
Summary:Phospholipase A2 (PLA) is a biochemically fully defined glycoprotein, representing the main allergen of bee venom. We have established CD4+ T cell clones specific to PLA from subjects allergic and nonallergic to bee sting. By screening the epitope specificity of these clones with 62 synthetic overlapping dodecapeptides representing the PLA molecule, two immunogenic epitopes, PLA81-92 and PLA113-124, were identified. Additional screening, using longer peptides of up to 18 residues, revealed a third epitope at position PLA 45-62. These epitopes are recognized by specific T cell clones in association with HLA-DP and -DQ molecules, although HLA-DR-associated responses to PLA exist. Primary in vitro proliferation of unfractionated PBMC from bee sting allergic, hyposensitized, or hyperimmune subjects to PLA-derived peptides revealed the same immunogenic sites as found in the T cell clones. Among the different groups of individuals, proliferative responses to the PLA molecule and fragments thereof were generally higher in allergic patients than in nonallergic subjects. Thus, at least three linear epitopes are involved in T cell recognition of PLA, independently whether or not subjects are allergic.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-1767
1550-6606
1550-6606
DOI:10.4049/jimmunol.150.8.3582